# A Study of the Safety and Effectiveness of Levofloxacin Compared With Lomefloxacin in the Treatment of Complicated Urinary Tract Infections

> **NCT00258102** · PHASE3 · COMPLETED · sponsor: **Johnson & Johnson Pharmaceutical Research & Development, L.L.C.** · enrollment: 603 (actual)

## Conditions studied

- Urinary Tract Infections
- Bacterial Infections
- Bacteriuria
- Urologic Diseases

## Interventions

- **DRUG:** Levofloxacin

## Key facts

- **NCT ID:** NCT00258102
- **Lead sponsor:** Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1993-01
- **Primary completion:** —
- **Final completion:** 1995-01
- **Target enrollment:** 603 (ACTUAL)
- **Last updated:** 2011-06-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00258102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00258102, "A Study of the Safety and Effectiveness of Levofloxacin Compared With Lomefloxacin in the Treatment of Complicated Urinary Tract Infections". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00258102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*